Saved source record
Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.
This is a source-metadata record last found in a complete check on Sep 24, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: Exact-ID Europe PMC status checked Sep 25, 2026. No retraction or correction publication-type marker was listed in that response. This does not rule out other updates.
Study metadata
- Study type
- Original study
- Study category (metadata hint)
- Human
- Published
- 2017
- Authors
- Clemmons DR, Miller S, Mamputu JC
- Journal or registry
- PloS one
- Registry study design
- Not reported
- Registry enrollment
- Not reported
- Funding agencies
- Not reported in source metadata
- Identifiers
- DOI: 10.1371/journal.pone.0179538 · PMID: 28617838 · PMCID: PMC5472315
- First found
- Sep 24, 2026
- Last found
- Sep 24, 2026
Original sources
Browse saved studies · Search live sources